DNLI DENALI THERAPEUTICS INC

Ownership history in Advisory Services Network, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in DENALI THERAPEUTICS INC (DNLI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2020 Q4)
Avg. % of fund
0.01%
First filed
2020 Q1
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 39 -270 -87.4% 0.00% $566 $14.52
2023 Q4 ADDED 309 +9 +3.0% 0.00% $7K $21.46
2023 Q1 UNCHANGED 300 0% 0.00% $7K $23.04
2022 Q4 REDUCED 300 -1,622 -84.4% 0.00% $8K $27.81
2021 Q2 REDUCED 1,922 -1,717 -47.2% 0.00% $151K $78.44
2021 Q1 REDUCED 3,639 -2,071 -36.3% 0.01% $208K $57.10
2020 Q4 ADDED 5,710 +91 +1.6% 0.02% $478K $83.76
2020 Q3 ADDED 5,619 +373 +7.1% 0.01% $201K $35.83
2020 Q1 INITIATED 5,246 0.01% $92K $17.51
% of Fund (quarterly)    DNLI price (monthly, adj. close)
← Back to Advisory Services Network, LLC Holdings